Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy and functional recovery after switching from paliperidone palmitate injections to oral antipsychotics in schizophreni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral antipsychotics (unspecified)
  • Paliperidone palmitate (Invega Sustenna) (paliperidone palmitate)

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: Schizophrenia | Phase 4 | Status: NOT_YET_RECRUITING